Keyphrases
Neuroblastoma
100%
Tumor
32%
Pediatric
27%
Pediatric Tumors
23%
Neuroblastoma Cells
18%
Children with Cancer
18%
Pediatric Cancer
17%
High-risk Neuroblastoma
16%
Organoids
16%
Pediatric Oncology
15%
Childhood Cancer
14%
T Cells
14%
Precision Oncology
14%
Therapeutic Target
14%
Innovative Therapies
13%
Tumor Organoids
12%
Anti-GD2
11%
High-throughput Screening
10%
Tumor Cells
10%
Drug Development
9%
Cancer Research
9%
Pediatric Malignancy
9%
Single-cell RNA Sequencing (scRNA-seq)
9%
Genetic Modification
8%
MHC Class II
8%
Tumor Subtype
8%
Clinical Benefit
8%
Molecular Profiling
7%
Therapeutic Vulnerabilities
7%
Neuroblastoma Tumor
7%
Targeted Treatment
7%
Natural Killer Cells
7%
Adoptive Cell Therapy
7%
Clinical Trials
7%
Patient-derived Organoids
7%
Neutrophils
7%
Cas9 Protein
7%
High Risk
7%
Neuroblastoma Cell Line
7%
Cyclin-dependent Kinase 4 (CDK4)
7%
Integrative Analysis
7%
Aberrations
6%
Dinutuximab
6%
Targeted Drugs
6%
TIGIT
6%
Precision Medicine
6%
Nectin-2
6%
Drug Development Strategy
6%
International Society
6%
Europe
6%
Cancer Surveillance
6%
RNA Sequencing (RNA-seq)
6%
Rhabdoid Tumor
6%
MYCN Amplification
6%
Relapsed or Refractory
6%
Rhabdomyosarcoma
6%
Drug Screening
5%
High-throughput
5%
Cancer Predisposition Syndrome
5%
Combination Trials
5%
Preclinical Testing
5%
Granulocyte Colony-stimulating Factor (G-CSF)
5%
Adult Cancer
5%
RAS-MAPK Pathway
5%
Drug Sensitivity
5%
Therapeutic Potential
5%
Immunomodulatory
5%
Solid Tumors
5%
Medicine and Dentistry
Ganglioneuroblastoma
85%
Pediatrics
48%
Neoplasm
46%
Organoid
29%
Pediatric Cancer
27%
Childhood Cancer
27%
Malignant Neoplasm
24%
Solid Malignant Neoplasm
22%
Immunotherapy
20%
T Cell
19%
Disease
15%
Neuroblastoma Cell
15%
Oncology
15%
Cancer
13%
RNA Sequence
13%
Experimental Therapy
12%
Targeted Therapy
11%
Adolescence
11%
Personalized Medicine
10%
In Vitro
9%
Cancer Research
8%
High Throughput Screening
8%
Cytotoxicity
8%
Tumor Cell
7%
Cell Therapy
7%
Drug Screening
7%
Immunity
7%
Clinical Trial
7%
Rhabdomyosarcoma
6%
Biological Marker
6%
DNA Repair
6%
Molecular Profiling
6%
Protein P53
6%
Disease Predisposition
6%
Neutrophil
6%
Messenger RNA
6%
Cancer Epidemiology
6%
Dinutuximab
6%
Natural Killer Cell
5%
Cancer Susceptibility
5%
Intracranial Tumor
5%
Progression Free Survival
5%
Neuroblastoma Cell Line
5%